Search
GT Biopharma Inc
GTBPAdd to Watchlist
0.490USD
+0.050+11.30%
Close 06/30, 16:00（ET）Quotes delayed by 15 min
17.66MMarket Cap
LossP/E TTM
GT Biopharma Inc Earnings Date
Period
FY2025 Earnings Date
Revenue(YoY)
--
--
EPS(YoY)
-6.25
9.93%
Analyst Rating
BUY
2026-06-30
Financial Indicators
EPS
Revenue
Net Profit
Net Margin
Gross Margin
Debt to assets ratio
ROE
ROA
Relevant data have not been disclosed by the company yet.
Income Statement
Revenue
Operating profit
Net Profit
Relevant data have not been disclosed by the company yet.
Balance Sheet
Current assets
Total current liabilities
Total assets
Total liabilities
Total equity
Relevant data have not been disclosed by the company yet.
Cash Flow Statement
Net operating income
Net investment
Net financing
Relevant data have not been disclosed by the company yet.
FAQs
What are the current assets of GT Biopharma Inc?
According to GT Biopharma Inc's FY2025 earnings report, its current assets were 8.11M, with a year-on-year change of 91.54.
What are the total assets of GT Biopharma Inc?
According to GT Biopharma Inc's FY2025 earnings report, its total assets of GT Biopharma Inc were 8.11M, with a year-on-year change of 91.54.
What are the total liabilities of GT Biopharma Inc?
According to GT Biopharma Inc's FY2025 earnings report, its total liabilities of GT Biopharma Inc were 2.32M, with a year-on-year change of -60.71.
What is the total equity of GT Biopharma Inc?
According to GT Biopharma Inc's FY2025 earnings report, its total equity of GT Biopharma Inc was 5.79M, with a year-on-year change of 446.53.
What is the net financing of GT Biopharma Inc?
According to GT Biopharma Inc's FY2025 earnings report, its net financing of GT Biopharma Inc was 15.78M, with a year-on-year change of 430.07.
What is the Earnings Per Share (EPS) of GT Biopharma Inc?
According to GT Biopharma Inc's FY2025 earnings report, its Earnings Per Share (EPS) was -6.25, with a year-on-year change of 9.93.
What is the Return on Equity (ROE) of GT Biopharma Inc?
According to GT Biopharma Inc's FY2025 earnings report, its Return on Equity (ROE) was -1674.31, with a year-on-year change of -269.16.
What is the Return on Assets (ROA) of GT Biopharma Inc?
According to GT Biopharma Inc's FY2025 earnings report, its Return on Assets (ROA) was -459.62, with a year-on-year change of -220.24.
What is the operating profit of GT Biopharma Inc?
According to GT Biopharma Inc's FY2025 earnings report, its operating profit was -12.42M, with a year-on-year change of 13.52.
